Origene Technologies

OriGene Technologies was founded in 1997 as a research tool company focused upon the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector.

OriGene Technologies uses high-throughput gene cloning and gene expression profiling to develop commercially available products for pharmaceutical, biotechnology, and academic research and discovery applications. OriGene's flagship product is the cDNA clone collection, a searchable gene bank of over 30,000 human full-length cDNA clones from our pre-made TrueClone Collection and our TrueClone Custom Cloning program. These cDNAs are suitable for transfection and in vivo or direct in vitro expression. In addition, OriGene offers unique gene expression products such as TissueScan cancer qPCR arrays for biomarker discovery and validation. In October 2009, OriGene acquired Marligen Biosciences, Inc., and now offers nucleic acid purification products and Luminex multiplex detection assays for microRNA and transcription factor profiling.

OriGene prides itself on being the cDNA clone partner of choice for the biomedical research community. Pioneering the development of patented processes for the isolation of full-length cDNA and rapid expression profiling techniques, In combination with related gene expression reagents, our offerings enable high-throughput functional analysis and the determination of disease specificity. OriGene is committed to develop technologies and applications focusing on System Biology approaches to gene function analysis.

Origene also has shRNA libraries and clones for siRNA work. It also has a large collection of miRNA clones, antibodies and expression lysates.

Visit Site : www.origene.com